Benzinga | Nov 6, 2020 06:34AM EST

Immunogen Q3 EPS $(0.13) Beats $(0.18) Estimate, Sales $18.20M Beat $15.36M Estimate

Immunogen (NASDAQ:IMGN) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 13.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $18.20 million which beat the analyst consensus estimate of $15.36 million by 18.49 percent. This is a 37.04 percent increase over sales of $13.28 million the same period last year.